Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oury Monchi

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Association of rare variants in <i>ARSA</i> with Parkinson's diseaseKonstantin Senkevich, Mariia Beletskaia, Aliza Dworkind, et al.
HGG Advances|December 11, 2025
Lack of association between G6PD variants and Parkinson diseaseLeah V Chifamba, Sitki Cem Parlar, Lang Liu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 29, 2023
Association of Rare Variants in ARSA with Parkinson's DiseaseKonstantin Senkevich, Mariia Beletskaia, Aliza Dworkind, et al.
Journal of Parkinson'S Disease|September 20, 2024
Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortMarisa Cressatti, Gabriel D Pinilla-Monsalve, Mathieu Blais, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 23, 2026
The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-AnalysisLeah V Chifamba, Sitki Cem Parlar, Emma N Somerville, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
The <i>GBA1</i> p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-AnalysisLeah V Chifamba, Sitki Cem Parlar, Emma N Somerville, et al.
Brain : a Journal of Neurology|November 12, 2022
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's diseaseKonstantin Senkevich, Cornelia E Zorca, Aliza Dworkind, et al.
Journal of Parkinson'S Disease|December 24, 2019
The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal BiorepositoryZiv Gan-Or, Trisha Rao, Etienne Leveille, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2019
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility SystemThilo van Eimeren, Angelo Antonini, Daniela Berg, et al.
Research Square|April 2, 2024
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJace Jones-Tabah, Kathy He, Konstantin Senkevich, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Association of rare variants in <i>ARSA</i> with Parkinson's diseaseKonstantin Senkevich, Mariia Beletskaia, Aliza Dworkind, et al.
HGG Advances|December 11, 2025
Lack of association between G6PD variants and Parkinson diseaseLeah V Chifamba, Sitki Cem Parlar, Lang Liu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 29, 2023
Association of Rare Variants in ARSA with Parkinson's DiseaseKonstantin Senkevich, Mariia Beletskaia, Aliza Dworkind, et al.
Journal of Parkinson'S Disease|September 20, 2024
Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortMarisa Cressatti, Gabriel D Pinilla-Monsalve, Mathieu Blais, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 23, 2026
The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-AnalysisLeah V Chifamba, Sitki Cem Parlar, Emma N Somerville, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
The <i>GBA1</i> p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-AnalysisLeah V Chifamba, Sitki Cem Parlar, Emma N Somerville, et al.
Brain : a Journal of Neurology|November 12, 2022
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's diseaseKonstantin Senkevich, Cornelia E Zorca, Aliza Dworkind, et al.
Journal of Parkinson'S Disease|December 24, 2019
The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal BiorepositoryZiv Gan-Or, Trisha Rao, Etienne Leveille, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2019
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility SystemThilo van Eimeren, Angelo Antonini, Daniela Berg, et al.
Research Square|April 2, 2024
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJace Jones-Tabah, Kathy He, Konstantin Senkevich, et al.
Pageof 16